< 1 minute read
Feb. 9, 2022
KB-0742: an Ultraselective Inhibitor of Cyclin-Dependent Kinase CDK9
Kronos CDK9 Inhibitor
selective CDK9 inhibitor oral Ph. I candidate for MYC-amp tumors from microarray binding assay with lysate KB-0742 Kronos Bio, Cambridge, MA
Loading...
